» Articles » PMID: 39789322

Integrated Analysis of Single-cell and Bulk-RNA Sequencing for the Cellular Senescence in Prognosis of Lung Adenocarcinoma

Overview
Journal Sci Rep
Date 2025 Jan 9
PMID 39789322
Authors
Affiliations
Soon will be listed here.
Abstract

Non-small cell lung cancer (NSCLC), half of which are lung adenocarcinoma (LUAD), is one of the most widely spread cancers in the world. Telomerase, which maintains telomere length and chromosomal integrity, enables cancer cells to avoid replicative senescence. When telomerase is inhibited, cancer cells' senescence began, preventing them from growing indefinitely. Cellular senescence and telomeres are intrinsically linked. As of yet, still laking a systematic study of the involvement of telomere-senescence related genes in lung adenocarcinoma development. In this study, myeloid cells were identified as the cell type which are most correlated with cellular senescence based on its highest telomere-related gene activity. GO, KEGG, GSEA and GSVA analyses were used to explore the biological function of telomere-senescence related genes in LUAD. The combined analysis of single-cell RNA-sequencing and bulk-RNA sequencing identified a gene signature composed of 14 genes which can accurately predict the prognosis of patients with LUAD. In one training and four validation sets, patients with higher Telomere Related Gene Signature (TRGS) had a worse prognosis than those with lower TRGS. Different TRGS patient groups showed varying degrees of immune cell infiltration, frequency of gene missense mutation, sensitivity to different drugs, and tumor mutation burden (TMB). Collectively, we developed a brand new signature composed of telomere-senescence related genes that can accurately predicts patients' prognosis in LUAD, which provides new insights for future research into the role of cellular senescence in LUAD.

References
1.
Abdallah P, Luciano P, Runge K, Lisby M, Geli V, Gilson E . A two-step model for senescence triggered by a single critically short telomere. Nat Cell Biol. 2009; 11(8):988-93. PMC: 4025917. DOI: 10.1038/ncb1911. View

2.
Lu T, Yang X, Huang Y, Zhao M, Li M, Ma K . Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag Res. 2019; 11:943-953. PMC: 6345192. DOI: 10.2147/CMAR.S187317. View

3.
Vertecchi E, Rizzo A, Salvati E . Telomere Targeting Approaches in Cancer: Beyond Length Maintenance. Int J Mol Sci. 2022; 23(7). PMC: 8998427. DOI: 10.3390/ijms23073784. View

4.
Li J, Wang Y, Li Q, Xue J, Wang Z, Yuan X . Downregulation of FBP1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Gastric Cancer via Regulating Epithelial-Mesenchymal Transition. PLoS One. 2016; 11(12):e0167857. PMC: 5158319. DOI: 10.1371/journal.pone.0167857. View

5.
Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View